Riskpilot← Back to searchSign inGet full accessWahlbeck & Hammarström AB
ABActiveOrg 5591131239NorrtäljeResidential care activities for persons living with or having a diagnosis of a mental illness or substance abuse · NACE 8720Est. 20170 employees
Revenue 2025
SEK 0
EBITDA margin
—
+86% vs 2024
Equity ratio
95.6%
Financial strength
Net profit 2025
SEK 902K
+478% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -98K | +86% |
| Net profit | SEK 902K | +478% |
| Total assets | SEK 5,4M | +20% |
| Equity | SEK 5,1M | +21% |
| Employees | 0 | — |
Legal name
Wahlbeck & Hammarström AB
Org number
5591131239
Legal form
Aktiebolag
NACE code
8720 · Residential care activities for persons living with or having a diagnosis of a mental illness or substance abuse
Founded
22 maj 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva behandlingshem och öppenvårdsverksamhet för ungdomar och därmed förenlig verksamhet.
Address
Norrtälje
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 996 | 156 | 0 | 0 | 0 |
| Staff expenses | — | −69 | −0 | −0 | −0 |
| EBITDA | −429 | −58 | −1 639 | −714 | −98 |
| Depreciation & amort. | −4 | −16 | — | — | — |
| EBIT | −433 | −74 | −1 639 | −714 | −98 |
| Net financials | 896 | 2 976 | 4 098 | 476 | 1 000 |
| Profit before tax | 464 | 2 902 | 2 458 | −238 | 902 |
| Tax | −0 | — | −69 | — | — |
| Net profit | 464 | 2 902 | 2 389 | −238 | 902 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 320 | 5 493 | 4 837 | 4 487 | 5 369 |
| Equity | 578 | 3 480 | 4 669 | 4 231 | 5 133 |
| Long-term debt | 0 | — | — | 142 | 162 |
| Short-term debt | 3 741 | 2 013 | 168 | 114 | 74 |
| Total debt | 3 741 | 2 013 | 168 | 256 | 236 |
EBITDA margin
-9792300.0%
This company
15.8%
Market median
-61976682% vs market
20212025
Equity ratio
95.6%
This company
38.2%
Market median
+150% vs market
20212025
Return on equity
17.6%
This company
18.4%
Market median
+4% vs market
20212025
Net profit margin
90181900.0%
This company
8.1%
Market median
+1113356690% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PM External Signatory | External Signatory | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Wahlbeck & Hammarström AB 
Suddamin Care i Norrtälje ABBoard members of Wahlbeck & Hammarström AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pia Maria Fondelius Aschan | External Signatory | 0 companies |
| Maud Ingrid Annelie Wallfelt | Board of Directors | 0 companies |
| Emelie Josefine Eugénia Hjelm Bonin | Deputy Board Member | 0 companies |
| Sebastian Wahlbäck | Board of Directors | 0 companies |
| Reine Per-Erik Berglind | Deputy Board Member | 0 companies |